Fate Therapeutics Statistics
Total Valuation
FATE has a market cap or net worth of $325.78 million. The enterprise value is $227.75 million.
| Market Cap | 325.78M |
| Enterprise Value | 227.75M |
Important Dates
The next estimated earnings date is Tuesday, August 11, 2026, after market close.
| Earnings Date | Aug 11, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
FATE has 116.56 million shares outstanding. The number of shares has increased by 1.02% in one year.
| Current Share Class | 116.56M |
| Shares Outstanding | 116.56M |
| Shares Change (YoY) | +1.02% |
| Shares Change (QoQ) | +0.66% |
| Owned by Insiders (%) | 1.49% |
| Owned by Institutions (%) | 54.79% |
| Float | 101.86M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 51.58 |
| Forward PS | 65.30 |
| PB Ratio | 1.81 |
| P/TBV Ratio | 1.81 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 36.06 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.85, with a Debt / Equity ratio of 0.43.
| Current Ratio | 5.85 |
| Quick Ratio | 5.75 |
| Debt / Equity | 0.43 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -55.50% and return on invested capital (ROIC) is -27.52%.
| Return on Equity (ROE) | -55.50% |
| Return on Assets (ROA) | -25.29% |
| Return on Invested Capital (ROIC) | -27.52% |
| Return on Capital Employed (ROCE) | -54.41% |
| Weighted Average Cost of Capital (WACC) | 14.66% |
| Revenue Per Employee | $39,230 |
| Profits Per Employee | -$806,876 |
| Employee Count | 161 |
| Asset Turnover | 0.02 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +147.35% in the last 52 weeks. The beta is 2.52, so FATE's price volatility has been higher than the market average.
| Beta (5Y) | 2.52 |
| 52-Week Price Change | +147.35% |
| 50-Day Moving Average | 2.36 |
| 200-Day Moving Average | 1.52 |
| Relative Strength Index (RSI) | 56.18 |
| Average Volume (20 Days) | 4,952,877 |
Short Selling Information
The latest short interest is 7.43 million, so 6.38% of the outstanding shares have been sold short.
| Short Interest | 7.43M |
| Short Previous Month | 10.82M |
| Short % of Shares Out | 6.38% |
| Short % of Float | 7.30% |
| Short Ratio (days to cover) | 1.54 |
Income Statement
In the last 12 months, FATE had revenue of $6.32 million and -$129.91 million in losses. Loss per share was -$1.09.
| Revenue | 6.32M |
| Gross Profit | -81.15M |
| Operating Income | -138.32M |
| Pretax Income | -129.91M |
| Net Income | -129.91M |
| EBITDA | -125.84M |
| EBIT | -138.32M |
| Loss Per Share | -$1.09 |
Balance Sheet
The company has $174.82 million in cash and $76.79 million in debt, with a net cash position of $98.04 million or $0.84 per share.
| Cash & Cash Equivalents | 174.82M |
| Total Debt | 76.79M |
| Net Cash | 98.04M |
| Net Cash Per Share | $0.84 |
| Equity (Book Value) | 179.71M |
| Book Value Per Share | 1.55 |
| Working Capital | 148.84M |
Cash Flow
In the last 12 months, operating cash flow was -$103.10 million and capital expenditures -$5.00 million, giving a free cash flow of -$108.09 million.
| Operating Cash Flow | -103.10M |
| Capital Expenditures | -5.00M |
| Depreciation & Amortization | 12.49M |
| Net Borrowing | n/a |
| Free Cash Flow | -108.09M |
| FCF Per Share | -$0.93 |
Margins
| Gross Margin | n/a |
| Operating Margin | -2,190.06% |
| Pretax Margin | -2,056.79% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
FATE does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.02% |
| Shareholder Yield | -1.02% |
| Earnings Yield | -39.88% |
| FCF Yield | -33.18% |
Analyst Forecast
The average price target for FATE is $5.41, which is 93.56% higher than the current price. The consensus rating is "Buy".
| Price Target | $5.41 |
| Price Target Difference | 93.56% |
| Analyst Consensus | Buy |
| Analyst Count | 12 |
| Revenue Growth Forecast (3Y) | -13.01% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
FATE has an Altman Z-Score of -7.88 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -7.88 |
| Piotroski F-Score | 1 |